Identifying Drugs to Treat Age-Dependent Neurodegeneration

确定治疗年龄依赖性神经退行性疾病的药物

• 批准号: 7611510
• 负责人: KIM D. FINLEY
• 金额: $ 9.83万
• 依托单位: EXPRESSION DRUG DESIGNS, LLC
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-03-15 至 2010-08-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7611510
• 关键词: Acceleration; Address; Adult; Adverse effects; Affect; Age; Aging; Alzheimer' s Disease; Animal Model; Area; Autophagocytosis; Behavioral; Biological Assay; Biological Models; Brain; Cells; Complex; Coupled; Curcumin; Data; Defect; Development; Disease; Drosophila genus; Drug Combinations; Employee Strikes; Epigallocatechin Gallate; Excision; Food; Genes; Genetic; Goals; Health; Human; Huntington Disease; Immunosuppression; Individual; Legal patent; Life Cycle Stages; Longevity; Lysosomes; Measures; Memory; Methods; Modeling; Mus; Mutation; Nerve Degeneration; Nervous System Physiology; Nervous system structure; Neurodegenerative Disorders; Neurons; Neurophysiology - biologic function; Oxidative Stress; Pathway interactions; Peptides; Pharmaceutical Preparations; Phenotype; Photoreceptors; Physiological Processes; Physiology; Plants; Play; Preparation; Proteins; Regulation; Relative (related person); Research; Role; Screening procedure; Signal Pathway; Sirolimus; Symptoms; System; Tea; Techniques; Testing; Therapeutic Uses; Time; Tissues; Toxic effect; Transgenic Organisms; Ubiquitin; Vertebrates; Vesicle; Work; age related; behavior change; cytotoxic; design; dosage; drug efficacy; drug testing; feeding; fly; genetic analysis; in vivo; in vivo Model; kinase inhibitor; nervous system disorder; neuron loss; neurotoxicity; normal aging; novel; novel therapeutics; polyglutamine; polyphenol; protein aggregate; protein misfolding; public health relevance; relating to nervous system; trafficking

DESCRIPTION (provided by applicant): During normal aging and in the progression of many neurodegenerative disorders the accumulation of cellular damage can perturb the normal function of the nervous system and change behaviors and memory. A growing body of evidence shows that the highly conserved macroautophagy pathway (autophagy) is involved in maintaining the mature nervous system by facilitating the bulk removal of cellular damage and protein aggregates. Recently we have examined the aging profiles of autophagy genes and found the pathway is significantly suppressed in the older Drosophila CNS. At the same time, cellular damage markers including insoluble ubiquitinated proteins (IUP) show a dramatic increase in older fly brains. Genetic analysis identifies mutations in key genes that also significantly shorten adult lifespans (35 to 60%) and cause progressive neural defects that share striking similarities to those seen in Alzheimer's patents. Both phenotypes are signs of accelerated aging and an inability of neurons to clear cellular damage effectively. Of greater significance is our recent observation that upregulating or enhancing the level of rate-limiting components of the pathway in the adult nervous system suppresses the normal age- dependent accumulation of cellular damage (IUP) and significantly extends adult longevity nearly 60%. Taken together both the acceleration and suppression of age-dependent phenotypes shows that modeling changes to the mature nervous system can be done effectively in Drosophila, in order to gain a greater understanding of cellular factors involved with aging and progressive neural decline. In this proposal we take advantage of the conserved function of autophagy and its regulation, and coupled this information together with Drosophila genetic and transgenic techniques to identify neural protective compounds that enhance autophagy and promote adult longevity and neural function. Studies in Aim 1 will use the GAL4/UAS system to express neural toxic peptides in photoreceptor cells or throughout the adult CNS. Compounds will be screened for their ability to reduce cytotoxic phenotypes associated with their expression in neural tissues and cells. For Aim 2 compounds and concentration ranges identified in Aim 1 will be used to examine the ability of drugs to enhance autophagy and clear cellular damage that naturally occurs in aging adult Drosophila nervous system. For Aim 3 once a select set of compounds are identified they will be used in long-term aging studies to test their ability to extend adult lifespans. In addition, unique drug combinations and treatment regimes can also be quickly design and rapidly tested due to the powerful genetics and compressed lifespans of Drosophila. The overall goal of this proposal is to better understand the critical role that clearance pathways play in aging and to develop a rapid in vivo method to design and test drugs that can be used for the treatment of human neurological disorders. PUBLIC HEALTH RELEVANCE: Alzheimer's disease and other age-related neurological disorders affect millions of people worldwide. At this time treatment options are limited and characterization of new therapeutic compounds requires the development of novel methods to systematically test drug efficacy. The research outlined in this proposal will develop rapid in vivo screening techniques in Drosophila that detect changes in neural degenerative phenotypes associated with aging and loss of neuronal damage-control pathways like autophagy.

描述（由申请人提供）：在正常衰老和许多神经退行性疾病的进展过程中，细胞损伤的积累会扰动神经系统的正常功能以及变化行为和记忆。越来越多的证据表明，高度保守的大自噬途径（自噬）通过促进细胞损伤和蛋白质聚集体的大量去除来维持成熟的神经系统。最近，我们检查了自噬基因的衰老谱，发现该途径在较旧的果蝇中心被显着抑制。同时，包括不溶性泛素化蛋白（IUP）在内的细胞损伤标志物显示出较老的苍蝇大脑的急剧增加。遗传分析确定了关键基因的突变，这些突变也显着缩短了成人寿命（35％至60％），并引起进行性神经缺陷，这些缺陷与与阿尔茨海默氏症专利中的突变相似。两种表型都是加速衰老的迹象，神经元无法有效清除细胞损伤。我们最近的观察结果更为重要，即成人神经系统中途径的限制率成分的水平抑制了细胞损伤（IUP）的正常年龄依赖性积累，并显着延长成人寿命近60％。综上所述，加速和抑制年龄依赖性表型表明，在果蝇中，对成熟神经系统的建模变化可以有效地进行，以便对与衰老和进行性神经下降有关的细胞因素有更深入的了解。在此提案中，我们利用自噬及其调节的保守功能，并将这些信息与果蝇遗传和转基因技术结合起来，以鉴定增强自噬并促进成人寿命和神经功能的神经保护化合物。 AIM 1中的研究将使用GAL4/UAS系统在感光细胞或整个成年CNS中表达神经毒性肽。将筛选化合物，以减少与神经组织和细胞表达相关的细胞毒性表型的能力。对于AIM 2，AIM 1中确定的化合物和浓度范围将用于检查药物增强自然型成人果蝇神经系统自然发生的自噬和清晰细胞损伤的能力。对于AIM 3，一旦确定了一组选择的化合物，它们将用于长期衰老研究中，以测试其延长成人寿命的能力。此外，由于果蝇的强大遗传学和压缩寿命，独特的药物组合和治疗方案也可以快速设计并迅速进行测试。该提案的总体目标是更好地理解清除途径在衰老中起着的关键作用，并开发一种快速的体内方法来设计和测试可用于治疗人类神经系统疾病的药物。公共卫生相关性：阿尔茨海默氏病和其他与年龄有关的神经系统疾病影响全球数百万的人。此时，治疗方案是有限的，新的治疗化合物的表征需要开发新的方法来系统地测试药物疗效。该提案中概述的研究将在果蝇中发展快速的体内筛查技术，该技术检测与衰老和神经元损伤控制途径（如自噬）相关的神经退行表型的变化。